| Literature DB >> 27601500 |
Stephanie Thompson1, Scott Klarenbach1, Anita Molzahn2, Anita Lloyd3, Iwona Gabrys4, Mark Haykowsky5, Marcello Tonelli6.
Abstract
OBJECTIVES: For people with end-stage renal disease requiring haemodialysis, exercise can improve aspects of quality of life (QoL). However, the relative benefits and risks of different types of exercise in this population are unknown. Therefore, this pilot study aimed to evaluate the feasibility of a main study evaluating the efficacy of cycling and resistance exercise each performed during the haemodialysis treatment on QoL.Entities:
Keywords: QUALITATIVE RESEARCH; REHABILITATION MEDICINE
Mesh:
Year: 2016 PMID: 27601500 PMCID: PMC5020875 DOI: 10.1136/bmjopen-2016-012085
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
A priori feasibility criteria and outcomes
| Feasibility criteria | Feasibility outcome |
|---|---|
| Recruitment | |
| Accrual: 28 participants over 12 weeks | A total of 31 participants over 12 weeks |
| Reason for non-participation: proportion of screened patients unwilling to be randomised must be ≤20% | No patients reported randomisation to exercise type as a reason for non-participation. |
| Fidelity to the protocol | |
| Drop out: ≤25% of study participants withdrawing participation | A total of 16% of participants dropped out:
Cycling n=1, transplanted Resistance n=1, injury from motor vehicle collision Combined n=1, moved dialysis unit Attention control n=2, nausea and vomiting; did not like exercise |
| Adherence (willingness of participants to participate): of all exercise sessions offered,* ≥70% were initiated | A total of 87% of prescribed exercise sessions were initiated:
Cycling 89% Weights 83% Combined 90% Attention control 86% |
| Adherence (accordance with the exercise prescription): of all exercise sessions offered, ≥70% were performed at the prescribed time/volume and intensity | A total of 86% of prescribed exercise sessions were performed as prescribed:
Cycling 87% Weights 84% Combined 88% Attention control 86% |
| Impact of the intervention | |
| Acceptability of the exercises: overall ≥50% of participants reporting that they would like to continue their current intradialytic exercise programme after the study is over | A total of 63% of participants said they would continue with their current exercise
Cycling 50% Weights 50% Combined 100% Stretching 38% |
| Change in the amount of physical activity performed overall: difference in the HAP scores between baseline and 12 weeks† | MAS:
Cycling vs no cycling 4.3 (−2.8, 11.5) p=0.3 Weights vs no weights −1.2 (−8.4, 6.0) p=0.7 Cycling vs no cycling 1.1 (−7.7, 9.9) p=0.8 Weights vs no weights −0.9 (−9.7, 7.8) p=0.7 |
| Difference in the proportion of participants who reported never exercising outside of HD time | Baseline: 39% of participants exercised almost never or never exercising vs 12 weeks: 29% of participants exercised almost never or never (p=0.55) |
| Contamination: any participant who adopted the exercise(s) of another intervention group during the study period | No participants from the cycling, weights or stretching groups reported performing the other group's exercise |
*Offered sessions exclude sessions lost to study dropout.
†Analysis performed for main effects adjusting for the baseline score and other factor.
AAS, adjusted activity score; HAP, Human Activity Profile; HD, haemodialysis; MAS, maximal activity score.
Figure 1RCT participant flow.
Baseline characteristics of trial participants
| All (n=31) | Cycling (n=8) | Weights (n=7) | Combined (n=8) | Stretching (n=8) | |
|---|---|---|---|---|---|
| Age* | 57.6 (49.2–75.1) | 66.9 (55.8–82.4) | 59.7 (45.9–81.4) | 60.3 (54.7–68.4) | 49.3 (43.0–62.3) |
| Sex (male) | 24 (77) | 8 (100) | 6 (86) | 3 (38) | 7 (88) |
| Time on HD (years) | 3.2 (1.7–4.4) | 3.7 (2.4–4.6) | 2.8 (2.0–4.0) | 2.9 (0.7–2.3) | 3.3 (1.2–6.2) |
| Ethnicity | |||||
| Caucasian | 19 (61) | 7 (88) | 3 (43) | 5 (63) | 4 (50) |
| Southeast Asian | 4 (13) | 1 (13) | 1 (14) | 1 (13) | 2 (25) |
| Aboriginal | 3 (10) | 0 | 2 (29) | 0 | 1 (13) |
| Other | 5 (16) | 0 | 1 (14) | 2 (25) | 1 (13) |
| Cause of ESRD | |||||
| Diabetes | 7 (22.6) | 2 (25) | 1 (14.3) | 2 (25) | 2 (25) |
| Glomerulonephritis | 10 (32.3) | 1 (12.5) | 5 (71.4) | 4 (50) | 0 |
| Hypertension | 1 (3.2) | 1 (12.5) | 0 | 0 | 0 |
| Polycystic kidney disease | 3 (9.7) | 1 (12.5) | 0 | 1 (12.5) | 1 (12.5) |
| Reflux/urological | 3 (9.7) | 1 (12.5) | 0 | 0 | 2 (25) |
| Other | 5 (16.1) | 2 (25) | 1 (14.3) | 0 | 2 (25) |
| Unknown | 2 (6.5) | 0 | 0 | 1 (12.5) | 1 (12.5) |
| BMI | 24.7 (21.6–29.9) | 23.6 (22.2–25.7) | 25.9 (24.6–29.9) | 25.3 (20.0–30.8) | 24.2 (20.4–33.8) |
| Diabetes | 15 (48) | 3 (38) | 3 (43) | 5 (63) | 4 (50) |
| Hypertension | 28 (90) | 8 (100) | 7 (100) | 7 (88) | 6 (75) |
| β blocker | 14 (45) | 4 (50) | 4 (57) | 3 (38) | 3 (38) |
| Coronary artery disease | 8 (26) | 4 (50) | 1 (14) | 2 (25) | 1 (13) |
| Heart failure | 7 (23) | 4 (50) | 3 (43) | 0 | 0 |
| QoL-PCS | 35±8 | 35±9 | 32±9 | 35±10 | 36±3 |
| Never exercise in leisure time | 12 (39) | 3 (38) | 4 (57) | 1 (13) | 4 (50) |
*Median (IQR interval); N with (%) or mean (±SD); totals do not always add to 100 due to rounding.
HD, haemodialysis; BMI, body mass index; ESRD, end-stage renal disease; QoL-PCS, quality of life-physical component summary.
Modifications to the study protocol following pretrial interviews with unit staff
| Trial protocol item | Initial plan/barrier | Modification |
|---|---|---|
| In-servicing format | Didactic sessions on the benefits of exercise in people with ESRD and one practical session with the exercise equipment | Two practical in-services on study procedures and equipment set-up |
| Workspace safety for staff | Exercise equipment as workspace hazard | Unit staff identified where equipment would be stored on the unit |
| Recruitment | Only study staff selects suitable candidates | Prior to enrolling a patient, the charge nurse was consulted regarding any dialysis-related safety concerns |
| Implementation | Include several unit staff members as volunteer ‘exercise champions’ to lead unit staff and liaise with study staff | No volunteers found. Identified four staff ‘point people’ who were already in leadership roles in the unit to informally check in with study staff on trial implementation |
ESRD, end-stage renal disease; IDE, intradialytic exercise.
Exercise parameters for the four exercise groups
| Cycling | Weights | Combined | Stretching/control | |
|---|---|---|---|---|
| Borg (Intensity, RPE) | 13±1 | 13±1 | 13±1 | 8±2 |
| Mean amount of exercise performed | 28.0±3.4 min | 36±12 (repetitions) | 27.5±8.8 min; | NAP |
| Systolic BP (mm Hg) | Pre: 136±20 | Pre: 123±26 | Pre: 121±28 | Pre: 119±22 |
| Diastolic BP (mm Hg) | Pre: 74±16 | Pre: 66±15 | Pre: 62±13 | Pre: 70±14 |
| Heart rate (bpm) | Pre: 66±14 | Pre: 71±12 | Pre: 69±11 | Pre: 78±17 |
BP, blood pressure; lbs, pounds; RPE, rating of perceived exertion.
Pre, post, and during exercise BP and HRs are a means±SD for initiated exercise sessions.
Secondary outcomes (QoL, tests of physical performance and strength)
| Outcome | Cycling (n=8) | Weights (n=7) | Combined (n=8) | Stretching/control (n=8) |
|---|---|---|---|---|
| PCS | ||||
| Mean difference and SD | 5.2±9.3 | 4.1±8.0 | 1.7±7.4 | 3.4±7.3 |
| Main effects (95% CI) | Cycling vs no cycling | Weights vs no weights | ||
| MCS | ||||
| Mean difference and SD | −2.3±10.7 | −3.4±9.1 | −1.5±5.9 | 0.70±7.5 |
| Main effects (95% CI) | Cycling vs no cycling | Weights vs no weights | ||
| SPPB | ||||
| Mean difference and SD | 1.9±2.4 | 1.4±1.9 | 1.0±1.2 | 0.63±1.2 |
| Main effects (95% CI)* | Cycling vs no cycling | Weights vs no weights | ||
| 6MWT | ||||
| Mean difference and SD | 42.3±88.8 | 54.9±52.9 | 39.0±76.8 | 0.8±44.0 |
| Main effects (95% CI) | Cycling vs no cycling | Weights vs no weights | ||
| STS 30 s | ||||
| Mean difference and SD | 0.9±2.2 | 1.6±2.7 | 1.4±3.5 | 1.4±4.3 |
| Main effects (95% CI) | Cycling vs no cycling | Weights vs no weights | ||
| 1-RM | ||||
| Mean difference and SD | 11.6±10.7 | 8.9±5.5 | 4.9±11.6 | 9.3±10.1 |
| Main effects (95% CI) | Cycling vs no cycling | Weights vs no weights | ||
1-RM, one repetition maximum; 6MWT, 6 min walk test; MCS, mental component score; PCS, physical component score); QoL, quality of life; SPPB, short physical performance battery; STS 30 s, 30 s sit-to-stand.
Models are adjusted for baseline score and the other main effect term.
*Interaction term included in the model (p=0.026).
Figure 2Adverse events occurring during the exercise session. Dialysis access complications=reneedling, haematoma.
Figure 3Adverse events occurring over the study period. Dialysis access complications=reneedling, haematoma.